[Mechanism of the antishock action of anisodamine (654-2)].
D000818:Animals; D002121:Calcium Channel Blockers; D000860:Hypoxia; D007421:Intestine, Small / Q000187:drug effects; D008247:Lysosomes / Q000187:drug effects; D008928:Mitochondria / Q000187:drug effects; D010643:Phenoxybenzamine / Q000627:therapeutic use; D012769:Shock / Q000188:drug therapy*; D012991:Solanaceous Alkaloids / Q000494:pharmacology / Q000627:therapeutic use*; D013565:Sympatholytics; D014665:Vasodilator Agents
D002121:Calcium Channel Blockers; D012991:Solanaceous Alkaloids; D013565:Sympatholytics; D014665:Vasodilator Agents; C003922:anisodamine; D010643:Phenoxybenzamine